{"id":3324,"date":"2022-06-27T16:50:14","date_gmt":"2022-06-27T06:50:14","guid":{"rendered":"https:\/\/orthocell.com\/us\/?p=3324"},"modified":"2022-06-28T08:57:09","modified_gmt":"2022-06-27T22:57:09","slug":"striateglobal-exclusive-license-and-manufacturing-agreement-with-biohorizons","status":"publish","type":"post","link":"\/americas\/striateglobal-exclusive-license-and-manufacturing-agreement-with-biohorizons\/","title":{"rendered":"Striate+\u2122 global exclusive license and manufacturing agreement with BioHorizons"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Orthocell (ASX:OCC) has signed a global exclusive license and manufacturing agreement for its FDA-cleared dental product, Striate+\u2122, with <a href=\"https:\/\/www.biohorizons.com\/\">BioHorizons Implant Systems Inc<\/a> &#8211; one of the largest dental implant companies in the world.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Under the terms of the agreement, BioHorizons has agreed to pay AUD $23.1 million (USD $16 million) for an exclusive license of intellectual property relating to Striate+\u2122. Orthocell will supply BioHorizons with Striate+\u2122products, and grant BioHorizons exclusive distribution rights for these products globally.\u00a0<\/span><\/p>\n<p><b>\u200b\u200b<\/b><b>President and CEO of BioHorizons, Steve Boggan, said:<\/b><\/p>\n<p><i><span style=\"font-weight: 400;\">\u201cWe are very pleased to partner with Orthocell to offer our valued customers a dental membrane with excellent handling properties and regenerative potential.\u00a0 Striate+\u2122 will be a highly complementary addition to our global biomaterials product portfolio for dental tissue regeneration.\u201d<\/span><\/i><\/p>\n<p><span style=\"font-weight: 400;\">BioHorizons is part of Henry Shein, Inc., a leading global provider of dental implants\u00a0 and tissue regeneration products for dentists and dental specialists. Striate+\u2122 will sit seamlessly amongst its portfolio of innovative dental implant and tissue regeneration products, designed to improve the lives of patients with missing teeth.\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/bit.ly\/OCC_StriateDeal\"><b>Click here to read today\u2019s ASX release.<\/b><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell (ASX:OCC) has signed a global exclusive license and manufacturing agreement for its FDA-cleared dental product, Striate+\u2122, with BioHorizons Implant Systems Inc &#8211; one of the largest dental implant companies in the world.\u00a0<\/p>\n","protected":false},"author":2,"featured_media":3325,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-3324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/3324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=3324"}],"version-history":[{"count":2,"href":"\/americas\/wp-json\/wp\/v2\/posts\/3324\/revisions"}],"predecessor-version":[{"id":3327,"href":"\/americas\/wp-json\/wp\/v2\/posts\/3324\/revisions\/3327"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/media\/3325"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=3324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=3324"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=3324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}